The document discusses optimizing pneumococcal conjugate vaccine (PCV) schedules. It provides an overview of PCV introduction and schedule changes in the UK from 1990-2015. Results are presented from a randomized controlled trial comparing immunogenicity of a 2+1 versus 1+1 PCV schedule in UK infants. The global landscape of PCV introduction is reviewed, noting opportunities to optimize schedules. Ongoing studies in multiple countries are exploring alternate PCV schedules to potentially simplify regimens while maintaining protection.